Mutation of at least one out of five genes (cyclin D1, C-MAF, FGFR3/MMSET, cyclin D3 and MAFB) seems to be a consistent finding in plasma cell myeloma which requires about three such rate limiting steps on average to manifest clinically. The gene discussed is NSD2; the disease is plasma cell myeloma.